How should the FDA regulate generative AI in medtech? Here are 5 takes

Patients, providers and medtech firms submitted hundreds of comments to the Food and Drug Administration on how the agency should approach generative AI in medical devices.

Leave a Comment

Your email address will not be published. Required fields are marked *

Scroll to Top